CD47 has emerged as a promising therapeutic target in cancer due to its widespread overexpression across numerous malignancies.[48] CD47 binds to SIRPα on macrophages and delivers a “don't eat me” signal, allowing cancer cells to evade phagocytic destruction. Here, SIRPA is linked to cancer.